cimb-logo

Journal Browser

Journal Browser

Feature Papers in Molecular Medicine

A topical collection in Current Issues in Molecular Biology (ISSN 1467-3045). This collection belongs to the section "Molecular Medicine".

Viewed by 1368

Editor


E-Mail Website
Collection Editor
1. Department of Biology, Zanvyl Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218-2685, USA
2. Fellow, National Academy of Inventors, Tampa, FL 33612, USA
3. Academician, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei 11529, Taiwan
Interests: chromatin structure and function; tetra-O-methyl nordihydroguaiaretic acid (M4N, terameprocol); oncogenic development in humans; chemotherapeutic drug treatments; viral replication; gene functions
Special Issues, Collections and Topics in MDPI journals

Topical Collection Information

Dear Colleagues,

This Topical Collection, entitled “Feature Papers in Molecular Medicine”, aims to collect high-quality research articles, communications, and review articles in cutting-edge fields of molecular medicine.

This Topical Collection publishes research that addresses the many faceted areas of this broad field and strives to understand the cause of disease on a molecular level and use this knowledge and basic research to create new preventions, diagnostics and treatments for various diseases and disorders. We encourage the submission of manuscripts that present innovative research on the physical, chemical, biological, bioinformatics and medical techniques that focus on molecular medicine.

  • Identifying molecular errors of disease;
  • Identifying genetic errors of disease;
  • Molecular interventions and methodologies;
  • Development of novel methods of treatment/therapeutics;
  • Disease mechanisms;
  • Innovative tools and technologies;
  • Disease diagnostics;
  • Molecular mechanisms of drugs;
  • Molecular and medical bioinformatics;
  • Molecular imaging techniques.

Prof. Dr. Ru Chih C. Huang
Collection Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pathogenesis
  • angiogenesis
  • autoimmune diseases
  • inflammatory
  • cancer
  • cardiovascular diseases
  • development and differentiation
  • endocrinology
  • genetics
  • epigenetics
  • hematology
  • hypoxia research
  • immunology
  • infectious diseases
  • metabolic disorders
  • neuroscience of diseases
  • regenerative medicine
  • prevention
  • therapeutics
  • stem cell research

Published Papers (2 papers)

2024

12 pages, 828 KiB  
Article
Impact of Zinc Oxide on the Development of Aspergillus-Induced Maxillary Sinusitis Rabbit Model
by Seung-Heon Shin, Mi-Kyung Ye, Dong-Won Lee and Mi-Hyun Choi
Curr. Issues Mol. Biol. 2024, 46(6), 5712-5723; https://doi.org/10.3390/cimb46060342 - 7 Jun 2024
Viewed by 345
Abstract
Aspergillus fumigatus is commonly found in the airway and is associated with airway inflammatory diseases. Zinc oxide (ZO) is known to be an essential microelement that facilitates fungal survival, growth, and proliferation. This study aimed to investigate the impact of ZO on A. [...] Read more.
Aspergillus fumigatus is commonly found in the airway and is associated with airway inflammatory diseases. Zinc oxide (ZO) is known to be an essential microelement that facilitates fungal survival, growth, and proliferation. This study aimed to investigate the impact of ZO on A. fumigatus-induced fungal sinusitis in rabbits. Twenty-eight New Zealand white rabbits were divided into four groups for this study. Group 1 (6 sides) was treated with intramaxillary phosphate buffer saline (PBS) served as the negative control, Group 2 (6 sides) received intramaxillary PBS and ZO, Group 3 (8 sides) was treated with intramaxillary A. fumigatus alone, and Group 4 (8 sides) treated with intramaxillary A. fumigatus with ZO. After 4 and 12 weeks, sinus mucosal cytokine and transcription factor expressions were determined. A histological analysis was performed to determine inflammatory cell infiltration, number of secretory cells, and mucosal thickness. Fungal biofilm formation was determined using confocal laser microscopy. The intramaxillary instillation of A. fumigatus conidia led to an increase in protein and mRNA expression of interleukin (IL)-1β and IL-8 in the maxillary sinus mucosa. They were associated with mitogen-activated protein kinase and activator protein-1. Furthermore, intramaxillary instillation of fungal conidia resulted in significant enhancement of inflammatory cell infiltration, epithelial thickening, and fungal biofilm formation. However, intramaxillary ZO did not have a significant impact on A. fumigatus-induced cytokine protein and mRNA expression, and inflammatory cell infiltration and epithelial thickness in sinonasal mucosa. While intramaxillary instillation of A. fumigatus increased mucosal inflammation, cytokine production, and biofilm formation, the intramaxillary application of ZO did not have a significant influence on inflammation in the maxillary sinus mucosa. Full article
19 pages, 1814 KiB  
Review
A Perfect Storm: The Convergence of Aging, Human Immunodeficiency Virus Infection, and Inflammasome Dysregulation
by Siva Thirugnanam and Namita Rout
Curr. Issues Mol. Biol. 2024, 46(5), 4768-4786; https://doi.org/10.3390/cimb46050287 - 15 May 2024
Viewed by 711
Abstract
The emergence of combination antiretroviral therapy (cART) has greatly transformed the life expectancy of people living with HIV (PWH). Today, over 76% of the individuals with HIV have access to this life-saving therapy. However, this progress has come with a new challenge: an [...] Read more.
The emergence of combination antiretroviral therapy (cART) has greatly transformed the life expectancy of people living with HIV (PWH). Today, over 76% of the individuals with HIV have access to this life-saving therapy. However, this progress has come with a new challenge: an increase in age-related non-AIDS conditions among patients with HIV. These conditions manifest earlier in PWH than in uninfected individuals, accelerating the aging process. Like PWH, the uninfected aging population experiences immunosenescence marked by an increased proinflammatory environment. This phenomenon is linked to chronic inflammation, driven in part by cellular structures called inflammasomes. Inflammatory signaling pathways activated by HIV-1 infection play a key role in inflammasome formation, suggesting a crucial link between HIV and a chronic inflammatory state. This review outlines the inflammatory processes triggered by HIV-1 infection and aging, with a focus on the inflammasomes. This review also explores current research regarding inflammasomes and potential strategies for targeting inflammasomes to mitigate inflammation. Further research on inflammasome signaling presents a unique opportunity to develop targeted interventions and innovative therapeutic modalities for combating HIV and aging-associated inflammatory processes. Full article
Show Figures

Figure 1

Back to TopTop